Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New group therapy aims to lower suicide risk in veterans

NCT ID NCT03653637

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested a group program called Project Life Force (PLF) against standard individual suicide safety planning for 294 veterans at high risk for suicide. PLF is a 10-session group that teaches coping skills and emotional regulation to strengthen safety plans. Researchers tracked suicidal behaviors and depression over 12 months to see if the group approach works better.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Project Life Force (group behavioral intervention)
What this could lead to
If successful, this group approach could offer a more effective way to help veterans manage suicidal thoughts and reduce suicide attempts.
What could go wrong
This is a completed trial with 294 participants, but results may not apply to all veterans or non-veterans. The intervention is behavioral, so individual outcomes can vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

294 people

The number who actually took part.

Started

Oct 2018

Finished

Mar 2024

Lead sponsor

A government agency

The lead sponsor is a US federal agency other than the NIH.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 89 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Discharge from inpatient unit for suicidal ideation or attempts, or placement on the high-risk suicide list maintained by suicide prevention coordinators * Completion of a safety plan during the past 6 months prior to entry * Concurrence from the patient's mental health provider for the Veteran to participate in the study and the provider is willing to work with the research team. Exclusion Criteria: * Unable to provide informed consent or complete study requirements * Unable to speak English * Cognitive difficulties that impair consent capacity * Unable or unwilling to provide at least one verifiable contact for emergency or tracking purposes * Unable to attend outpatient group treatment program or tolerate group therapy format * Active alcohol or opiate dependence requiring medically supervised withdrawal * Schizophrenia diagnosis * Participation in another intervention RCT

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Suicide are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Suicide

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA

    Philadelphia, Pennsylvania, 19104, United States

  • James J. Peters VA Medical Center, Bronx, NY

    The Bronx, New York, 10468-3904, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.